echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > JAHA: Assessing Cardiovascular Risk in Older HIV-Infected Individuals: Effects of Hepatitis C Virus Co-infection

    JAHA: Assessing Cardiovascular Risk in Older HIV-Infected Individuals: Effects of Hepatitis C Virus Co-infection

    • Last Update: 2022-09-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Background: Studies in different regions have shown that infected people have a 50 to 75 percent
    increased risk of cardiovascular disease compared to non-infected people.


    Traditional risk factors for cardiovascular disease (e.


    In people infected with PWH and HCV, increasing age is an independent risk factor
    for CVD.


    Objective: Our goal was to quantify the risk
    of major atherosclerotic type 1 myocardial infarction (T1MI) in the United States and Canada with and without chronic hepatitis C between 2000 and 2017.


    Methods and Results: We used data
    from NA-ACCORD (North American AIDS Cohort Research and Design Collaborative) starting antiretroviral therapy at PWH (ages 40-79 years) from January 1, 2000 to December 31, 2017.


    Figure 1 (A) incidence of myocardial infarction and (B) death and 95% ci (per 1000 person-years), classified
    by time period and hepatitis C virus co-infection.


    Table 1 Crude risk ratio and corrected risk ratio of myocardial infarction-related risk factors in HIV-infected patients in NA-ACCORD studies (N=23 361)

    Fig.


    Table 2 Adjusted risk ratio of central muscle infarction-related risk factors in NA-ACCORD HIV-infected patients by age (N=23 361)

    Conclusion: Hepatitis C virus co-infection has no significant correlation with an increased risk of T1MI; However, with age, people infected with HCV have a greater risk of developing T1MI than non-HCV infected people, and the situation
    of HCV infection should be considered when assessing the risk of CVD in older patients with PWH.


    Original source:

    Lang R, Humes E, Hogan B, et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.